Phase 1/2 Study of Stereotactic Body Radiation Therapy (SBRT) with or without GC4711 for Early Stage, Centrally Located or Large Non-Small Cell Lung Cancer (NSCLC)
Clinical Trial Grant
Administered By
Radiation Oncology
Awarded By
Galera Therapeutics, Inc.
Start Date
February 11, 2021
End Date
February 28, 2024
Administered By
Radiation Oncology
Awarded By
Galera Therapeutics, Inc.
Start Date
February 11, 2021
End Date
February 28, 2024